3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
37
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Multiple Myeloma
4
Neoplasms, Plasma Cell
3
Colorectal Neoplasms
3
Hematologic Neoplasms
2
Frailty
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Upper Excretory Tract Tumors
1
Transfusion-Related Acute Lung Injury
1
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sezary Syndrome
1
Sarcopenia
1
Sarcoglycanopathies
1
Psoriasis
1
Peripheral Arterial Disease
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Mycoses
1
Melanoma
1
Malnutrition
1
Interventions
Blood Specimen Collection
32
Surveys and Questionnaires
24
Radiotherapy
12
Gene Expression Profiling
12
Drug Therapy
12
Surgical Procedures, Operative
11
Bronchoscopy
10
Magnetic Resonance Spectroscopy
9
Immunotherapy
9
Immunohistochemistry
9
Tomography, X-Ray Computed
8
Specimen Handling
8
Observation
8
Amplified Fragment Length Polymorphism Analysis
8
Polymerase Chain Reaction
7
pembrolizumab
6
Psychiatric Rehabilitation
6
Interviews as Topic
6
Carboplatin
6
Thoracic Surgery, Video-Assisted
5
Reverse Transcriptase Polymerase Chain Reaction
5
Microarray Analysis
5
Liquid Biopsy
5
Chemoradiotherapy
5
Bevacizumab
5
durvalumab
4
Therapeutics
4
Paclitaxel
4
Nivolumab
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Neoplasms
×
Standard of Care
×
Clear all
NCT03137264
2019-11-07
RADIANCE
AstraZeneca
Completed
44 enrolled